Search

Author/Creator Fisher, Jan L.

1. A phase I, dose-escalation study of cyclical weekly oral temozolomide and weekly PEG-interferon alpha-2b in patients with refractory or advanced solid tumours. (December 2013)

Authors:
Coker, Shodeinde A.; Dandamudi, Uday B.; Beelen, Andrew P.; Crosby, Nancy A.; Fisher, Jan L.; Obrocea, Michael; Ernstoff, Marc S.; Lewis, Lionel D.
Journal:
Journal of chemotherapy
Issue:
Volume 25:Number 6(2013:Dec.)
Page Start:
362
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Regulatory T cells are not a strong predictor of survival for patients with glioblastoma. Issue 6 (24th January 2015)

Authors:
Thomas, Alissa A.; Fisher, Jan L.; Rahme, Gilbert J.; Hampton, Thomas H.; Baron, Udo; Olek, Sven; Schwachula, Tim; Rhodes, C. Harker; Gui, Jiang; Tafe, Laura J.; Tsongalis, Gregory J.; Lefferts, Joel A.; Wishart, Heather; Kleen, Jonathan; Miller, Michael; Whipple, Chery A.; de Abreu, Francine B.;...
Journal:
Neuro-oncology
Issue:
Volume 17:Issue 6(2015:Jun.)
Page Start:
801
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. The mitogen-activated protein kinase pathway plays a critical role in regulating immunological properties of BRAF mutant cutaneous melanoma cells. Issue 3 (June 2016)

Authors:
Whipple, Chery A.; Boni, Andrea; Fisher, Jan L.; Hampton, Thomas H.; Tsongalis, Gregory J.; Mellinger, Diane L.; Yan, Shaofeng; Tafe, Laura J.; Brinckerhoff, Constance E.; Turk, Mary J.; Mullins, David W.; Fadul, Camilo E.; Ernstoff, Marc S.
Journal:
Melanoma research
Issue:
Volume 26:Issue 3(2016)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗